In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles

References 42

1. 1.

   Ntziachristos V. Fluorescence molecular imaging. Annual review of biomedical engineering. 2006;8:1-33.

   Not in our library10.1146/annurev.bioeng.8.061505.095831

2. 2.

   Leblond F, Davis SC, Valdes PA, Pogue BW. Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications. Journal of Photochemistry and Photobiology B-Biology. 2010;98:77-94.

   Not in our library10.1016/j.jphotobiol.2009.11.007

3. 3.

   Corlu A, et al. Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. Optics Express. 2007;15:6696-6716.

   Not in our library10.1364/oe.15.006696

4. 4.

   Nguyen QT, et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:4317-4322.

   Not in our library10.1073/pnas.0910261107

5. 5.

   Kelly K, Alencar H, Funovics M, Mahmood U, Weissleder R. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Research. 2004;64:6247-6251.

   Not in our library10.1158/0008-5472.can-04-0817

6. 6.

   Richards-Kortum R, Sevick-Muraca E. Quantitative optical spectroscopy for tissue diagnosis. Annu Rev Phys Chem. 1996;47:555-606.

   Not in our library10.1146/annurev.physchem.47.1.555

7. 7.

   Berezin MY, Achilefu S. Fluorescence lifetime measurements and biological imaging. Chemical Reviews. 2010;110:2641-2684.

   Not in our library10.1021/cr900343z

8. 8.

   Weissleder R. A clearer vision for in vivo imaging. Nature Biotechnology. 2001;19:316-317.

   Not in our library10.1038/86684

9. 9.

   Bashkatov AN, Genina EA, Kochubey VI, Tuchin VV. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm. Journal of Physics D-Applied Physics. 2005;38:2543-2555.

   Not in our library

10. 10.

    Hilderbrand SA, Weissleder R. Near-infrared fluorescence: application to in vivo molecular imaging. Current Opinion in Chemical Biology. 2010;14:71-79.

    Not in our library10.1016/j.cbpa.2009.09.029

11. 11.

    Kobayashi H, Ogawa M, Alford R, Choyke PL, Urano Y. New strategies for fluorescent probe design in medical diagnostic imaging. Chemical Reviews. 2010;110:2620-2640.

    Not in our library10.1021/cr900263j

12. 12.

    Gao XH, Cui YY, Levenson RM, Chung LWK, Nie SM. In vivo cancer targeting and imaging with semiconductor quantum dots. Nature Biotechnology. 2004;22:969-976.

    Not in our library10.1038/nbt994

13. 13.

    Cubeddu R, Canti G, Taroni P, Valentini G. Time-gated fluorescence imaging forthe diagnosis oftumors in amurine model. Photochemistry and Photobiology. 1993;57:480-485.

    Not in our library10.1111/j.1751-1097.1993.tb02322.x

14. 14.

    Dahan M, et al. Time-gated biological imaging by use of colloidal quantum dots. Optics Letters. 2001;26:825-827.

    Not in our library10.1364/ol.26.000825

15. 15.

    Hall DJ, Sunar U, Farshchi-Heydari S, Han SH. In vivo simultaneous monitoring of two fluorophores with lifetime contrast using a full-field time domain system. Applied Optics. 2009;48:D74-D78.

    Not in our library10.1364/ao.48.000d74

16. 16.

    Erten A, et al. Enhancing magnetic resonance imaging tumor detection with fluorescence intensity and lifetime imaging. J Biomed Opt. 2010;15:066012.

    Not in our library10.1117/1.3509111

17. 17.

    Hall DJ, et al. Dynamic optical imaging of metabolic and NADPH oxidase-derived superoxide in live mouse brain using fluorescence lifetime unmixing. J Cereb Blood Flow Metab. 2012;32:23-32.

    Not in our library10.1038/jcbfm.2011.119

18. 18.

    Kumar ATN, et al. Feasibility of in vivo imaging of fluorescent proteins using lifetime contrast. Optics Letters. 2009;34:2066-2068.

    Not in our library10.1364/ol.34.002066

19. 19.

    Berezin MY, et al. Long fluorescence lifetime molecular probes based on near infrared pyrrolopyrrole cyanine fluorophores for in vivo imaging. Biophysical Journal. 2009;97:L22-L24.

    Not in our library10.1016/j.bpj.2009.08.022

20. 20.

    Anderson SHC, Elliott H, Wallis DJ, Canham LT, Powell JJ. Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions. Physica Status Solidi a-Applied Research. 2003;197:331-335.

    Not in our library

21. 21.

    Low SP, Voelcker NH, Canham LT, Williams KA. The biocompatibility of porous silicon in tissues of the eye. Biomaterials. 2009;30:2873-2880.

    Not in our library10.1016/j.biomaterials.2009.02.008

22. 22.

    Salonen J, Kaukonen AM, Hirvonen J, Lehto VP. Mesoporous silicon in drug delivery applications. J Pharm Sci. 2008;97:632-653.

    Not in our library10.1002/jps.20999

23. 23.

    Tasciotti E, et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nature Nanotechnology. 2008;3:151-157.

    Not in our library10.1038/nnano.2008.34

24. 24.

    Gu L, Park JH, Duong KH, Ruoslahti E, Sailor MJ. Magnetic luminescent porous silicon microparticles for localized delivery of molecular drug payloads. Small. 2010;6:2546-2552.

    Not in our library10.1002/smll.201000841

25. 25.

    Gelloz B, Kojima A, Koshida N. Highly efficient and stable luminescence of nanocrystalline porous silicon treated by high-pressure water vapor annealing. Applied Physics Letters. 2005;87:031107.

    Not in our library

26. 26.

    Anglin EJ, Cheng L, Freeman WR, Sailor MJ. Porous silicon in drug delivery devices and materials. Advanced Drug Delivery Reviews. 2008;60:1266-1277.

    Not in our library10.1016/j.addr.2008.03.017

27. 27.

    Cheng L, et al. Intravitreal properties of porous silicon photonic crystals: A potential self-reporting intraocular drugdelivery vehicle. British Journal of Ophthalmology. 2008;92:705-711.

    Not in our library10.1136/bjo.2007.133587

28. 28.

    Sze SM. Physics of Semiconductor Devices. 1981.

    Not in our library

29. 29.

    von Behren J, van Buuren T, Zacharias M, Chimowitz EH, Fauchet PM. Quantum confinement in nanoscale silicon: The correlation of size with bandgap and luminescence. Solid State Communications. 1998;105:317-322.

    Not in our library

30. 30.

    Cullis AG, Canham LT, Calcott PDJ. The structural and luminescence properties of porous silicon. Journal of Applied Physics. 1997;82:909-965.

    Not in our library

31. 31.

    Sailor MJ, Wu EC. Photoluminescence-Based Sensing With Porous Silicon Films, Microparticles, and Nanoparticles. Advanced Functional Materials. 2009;19:3195-3208.

    Not in our library

32. 32.

    Fisher B, Caruge JM, Zehnder D, Bawendi M. Room-temperature ordered photon emission from multiexciton states in single CdSe core-shell nanocrystals. Physical Review Letters. 2005;94:087403.

    Not in our library10.1103/physrevlett.94.087403

33. 33.

    Park JH, et al. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nature Materials. 2009;8:331-336.

    Not in our library10.1038/nmat2398

34. 34.

    Gallant P, et al. in Biomedical Topical Meeting, Vol OSA Technical Digest. 2004.

    Not in our library

35. 35.

    Merzlyak EM, et al. Bright monomeric red fluorescent protein with an extended fluorescence lifetime. Nature Methods. 2007;4:555-557.

    Not in our library10.1038/nmeth1062

36. 36.

    Iyer AK, Khaled G, Fang J, Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discovery Today. 2006;11:812-818.

    Not in our library10.1016/j.drudis.2006.07.005

37. 37.

    Peer D, et al. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology. 2007;2:751-760.

    Not in our library10.1038/nnano.2007.387

38. 38.

    Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Advanced Drug Delivery Reviews. 2002;54:631-651.

    Not in our library10.1016/s0169-409x(02)00044-3

39. 39.

    Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors. Journal of Cell Biology. 2010;188:759-768.

    Not in our library10.1083/jcb.200910104

40. 40.

    Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nature Reviews Cancer. 2006;6:583-592.

    Not in our library10.1038/nrc1893

41. 41.

    Sailor MJ. Porous Silicon in Practice: Preparation, Characterization, and Applications. 2012.

    Not in our library

42. 42.

    Buschmann V, Weston KD, Sauer M. Spectroscopic study and evaluation of red-absorbing fluorescent dyes. Bioconjugate Chemistry. 2003;14:195-204.

    Not in our library10.1021/bc025600x

Cited by papers we hold 2

• The shape and size of hydroxyapatite particles dictate inflammatory responses following implantation · 2017
  No notice
• A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.